Evidence map›Paper›PMID 37093471›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

High-Throughput Production and Optimization of Membrane Proteins After Expression in Mammalian Cells.

Nadisha Gamage, Harish Cheruvara, Peter J Harrison, James Birch, Charlie J Hitchman, Monika Olejnik, Raymond J Owens, Andrew Quigley

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Discovery of Therapeutic Antibodies Targeting Complex Multi-Spanning Membrane Proteins.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Nadisha GamageMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
Harish CheruvaraMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
Peter J HarrisonMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
James BirchMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
Charlie J HitchmanMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
Monika OlejnikMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK.
Raymond J OwensStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
Andrew QuigleyMembrane Protein Laboratory, Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK. andrew.quigley@diamond.ac.uk.
Research Complex at Harwell · GBDiamond Light Source · GBCentre for Human Genetics · GBUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-quality protein samples are an essential requirement of any structural biology experiment. However, producing high-quality protein samples, especially for membrane proteins, is iterative and time-consuming. Membrane protein structural biology remains challenging due to low protein yields and high levels of instability especially when membrane proteins are removed from their native environments. Overcoming the twin problems of compositional and conformational instability requires an understanding of protein size, thermostability, and sample heterogeneity, while a parallelized approach enables multiple conditions to be analyzed simultaneously. We present a method that couples the high-throughput cloning of membrane protein constructs with the transient expression of membrane proteins in human embryonic kidney (HEK) cells and rapid identification of the most suitable conditions for subsequent structural biology applications. This rapid screening method is used routinely in the Membrane Protein Laboratory at Diamond Light Source to identify the most successful protein constructs and conditions while excluding those that will not work. The 96-well format is easily adaptable to enable the screening of constructs, pH, salts, encapsulation agents, and other additives such as lipids.

Indexed as

MammalsMembrane ProteinsAnimalsHumansMembrane ProteinsExpression and purification screeningHigh-throughputMammalian cell cultureMembrane proteinsTransient expression

Identifiers

PMID37093471
OpenAlexW4366821904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.